We conducted a systematic examination of JCHAIN’s role in cancer and discovered that JCHAIN gene and protein expression was low in most cancers, including BRCA, COAD, LUSC, HNSC, and LIHC, as measured by pan-cancer analysis, and was also linked with immunostaging and molecular staging. Here, JCHAIN is linked to cancer.